Comparative Effectiveness of Rituximab Versus Ocrelizumab Using Real-world Evidence: A Canadian Propensity-score Matched Observational Study (P12-1.005)
To compare the effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis in a real-world setting.
Authors
- Robert Carruthers (ORCID: https://orcid.org/0000-0001-7085-1001)
- Dian Kuipers
- Tomáš Kalinčík (ORCID: https://orcid.org/0000-0003-3778-1376)
- Anthony Traboulsee (ORCID: https://orcid.org/0000-0002-0351-9639)
- Nathan Chu (ORCID: https://orcid.org/0000-0001-8721-1174)
- Izanne Roos (ORCID: https://orcid.org/0000-0003-0371-3666)
- Kyra West
- Jodie I. Roberts (ORCID: https://orcid.org/0000-0002-8544-3171)
- David W. C. Hunt (ORCID: https://orcid.org/0000-0001-9674-3543)
- Alice Schabas (ORCID: https://orcid.org/0000-0002-5925-1715)
- Virginia Devonshire
- Ana‐Luiza Sayao
- Jomana Morkous
Institutions
- The Royal Melbourne Hospital (AU)
- University of British Columbia (CA)
- The University of Melbourne (AU)
- University of Calgary (CA)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210534
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67